In fact, amplification of the SETD1A gene in a high fraction (24%) of patient-derived breast cancer clones engrafting in mice could be attributed to the mitotic and cell cycle competence acquired by these high SETD1A expressing tumor cells21. Here, SETD1A is linked to neoplasm.